ONCOLOGY RADIOPHARMACEUTICALS MARKET ANALYSIS
The global oncology radiopharmaceuticals market is estimated to be valued at US$ 3,462.8 million in 2021 and is expected to exhibit a CAGR of 6.0% during the forecast period (2021-2028).
Figure 1. Global Oncology Radiopharmaceuticals Market in Terms of Value (US$ million), By Region, 2021
Emerging use of radiopharmaceuticals as new cancer therapy is expected to drive the global oncology radiopharmaceuticals market growth during the forecast period.
Radiopharmaceuticals deliver radiation therapy directly and specifically to cancer cells...
Shift towards combination therapies is expected to propel the global oncology radiopharmaceuticals market growth over the forecast period.
The use of radiopharmaceuticals in combination with other therapies to improve the treatment is...
Forecast Period 2021 to 2028 CAGR: 45.7%
Figure 2. Global Oncology Radiopharmaceuticals Market Share (%), By Application, 2021
Global Oncology Radiopharmaceuticals Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 caused several challenges to cancer practices, especially to ensure continuity of treatment during this pandemic period...
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 